Actions and mode of actions of FGF19 subfamily members

被引：102

作者：

Fukumoto, Seiji ^{[1
]}

机构：

[1] Tokyo Univ Hosp, Dept Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan

来源：

ENDOCRINE JOURNAL | 2008年 / 55卷 / 01期

关键词：

hypophosphatemia; hyperphosphatemia; klotho; FGF;

D O I：

10.1507/endocrj.KR07E-002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fibroblast growth factors (FGFs) are Immoral factors with diverse biological functions. While most FGFs were shown to work as local factors regulating cell growth and differentiation, recent investigations indicated that FGF19 subfamily members, FGF15/19, FGF21 and FGF23 work as systemic factors. FGF 15/19 produced by intestine inhibits bile acid synthesis and FGF21 from liver is involved in carbohydrate and lipid metabolism. In addition, FGF23 was shown to be produced by bone and regulate phosphate and vitamin D metabolism. Furthermore, these FGFs require klotho or beta klotho for their actions in addition to canonical FGF receptors. It is possible that these FGFs together with their receptor systems might be targets for novel therapeutic measures in the future.

引用

页码：23 / 31

页数：9

共 52 条

[1] A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis
Araya, K
Fukumoto, S
Backenroth, R
Takeuchi, Y
Nakayama, K
Ito, N
Yoshii, N
Yamazaki, Y
Yamashita, T
Silver, J
Igarashi, T
Fujita, T
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10) : 5523 - 5527
[2] Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
[3] An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
Benet-Pagès, A
Orlik, P
Strom, TM
Lorenz-Depiereux, B
[J]. HUMAN MOLECULAR GENETICS, 2005, 14 (03) : 385 - 390
[4] FGF23 is processed by proprotein convertases but not by PHEX
Beret-Pagès, A
Lorenz-Depiereux, B
Zischka, H
White, KE
Econs, MJ
Strom, TM
[J]. BONE, 2004, 35 (02) : 455 - 462
[5] The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel
Chang, Q
Hoefs, S
van der Kemp, AW
Topala, CN
Bindels, RJ
Hoenderop, JG
[J]. SCIENCE, 2005, 310 (5747) : 490 - 493
[6] Identification of a hormonal basis for gallbladder filling
Choi, Mihwa
Moschetta, Antonio
Bookout, Angie L.
Peng, Li
Umetani, Michihisa
Holmstrom, Sam R.
Suino-Powell, Kelly
Xu, H. Eric
Richardson, James A.
Gerard, Robert D.
Mangelsdorf, David J.
Kliewer, Steven A.
[J]. NATURE MEDICINE, 2006, 12 (11) : 1253 - 1255
[7] Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Feng, Jian Q.
Ward, Leanne M.
Liu, Shiguang
Lu, Yongbo
Xie, Yixia
Yuan, Baozhi
Yu, Xijie
Rauch, Frank
Davis, Siobhan I.
Zhang, Shubin
Rios, Hector
Drezner, Marc K.
Quarles, L. Darryl
Bonewald, Lynda F.
White, Kenneth E.
[J]. NATURE GENETICS, 2006, 38 (11) : 1310 - 1315
[8] Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
Ferrari, SL
Bonjour, JP
Rizzoli, R
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) : 1519 - 1524
[9] A GENE (PEX) WITH HOMOLOGIES TO ENDOPEPTIDASES IS MUTATED IN PATIENTS WITH X-LINKED HYPOPHOSPHATEMIC RICKETS
FRANCIS, F
HENNIG, S
KORN, B
REINHARDT, R
DEJONG, P
POUSTKA, A
LEHRACH, H
ROWE, PSN
GOULDING, JN
SUMMERFIELD, T
MOUNTFORD, R
READ, AP
POPOWSKA, E
PRONICKA, E
DAVIES, KE
ORIORDAN, JLH
ECONS, MJ
NESBITT, T
DREZNER, MK
OUDET, C
PANNETIER, S
HANAUER, A
STROM, TM
MEINDL, A
LORENZ, B
CAGNOLI, M
MOHNIKE, KL
MURKEN, J
MEITINGER, T
[J]. NATURE GENETICS, 1995, 11 (02) : 130 - 136
[10] Hyperostosis-hyperphosphatemia syndrome:: A congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23
Frishberg, Yaacov
Ito, Nobuaki
Rinat, Choni
Yamazaki, Yuji
Feinstein, Sofia
Urakawa, Itaru
Navon-Elkan, Paulina
Becker-Cohen, Rachel
Yamashita, Takeyoshi
Araya, Kaori
Igarashi, Takashi
Fujita, Toshiro
Fukumoto, Seiji
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (02) : 235 - 242

← 1 2 3 4 5 6 →